TY - JOUR KW - Arthritis, Rheumatoid KW - Ataxia Telangiectasia KW - Autoimmune Diseases KW - Candidiasis, Cutaneous KW - Coccidioidomycosis KW - Communicable Diseases KW - Humans KW - Immunologic Deficiency Syndromes KW - Immunotherapy KW - leprosy KW - Neoplasms KW - Sarcoidosis KW - Transfer Factor KW - Wiskott-Aldrich Syndrome AU - Di Padova F AB -
The transfer factor is a tiny molecule capable of transferring the function of the T lymphocytes (immunological memory and retarded hypersensitivity) from a sensitized to a non-sensitized individual. The exact structure and action modalities of the molecule have not yet been precisely established. The difficulties involved in the study of the transfer factor are aggravated by the lack of any suitable experimental model. The attention of immunologists is attracted by this factor which opens up new prospects for the treatment of cancer, immunological deficiencies and certain infectious and autoimmune diseases. More profound research would appear useful to evaluate if and in what cases a potentiation of the immune mechanism can represent an alternative to immunosuppression.
BT - Minerva medica C1 - http://www.ncbi.nlm.nih.gov/pubmed/379697?dopt=Abstract DA - 1979 May 26 IS - 25 J2 - Minerva Med. LA - ita N2 -The transfer factor is a tiny molecule capable of transferring the function of the T lymphocytes (immunological memory and retarded hypersensitivity) from a sensitized to a non-sensitized individual. The exact structure and action modalities of the molecule have not yet been precisely established. The difficulties involved in the study of the transfer factor are aggravated by the lack of any suitable experimental model. The attention of immunologists is attracted by this factor which opens up new prospects for the treatment of cancer, immunological deficiencies and certain infectious and autoimmune diseases. More profound research would appear useful to evaluate if and in what cases a potentiation of the immune mechanism can represent an alternative to immunosuppression.
PY - 1979 SP - 1773 EP - 85 T2 - Minerva medica TI - [A new approach to immunotherapy: the transfer factor]. VL - 70 SN - 0026-4806 ER -